SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-003761
Filing Date
2024-01-11
Accepted
2024-01-11 08:31:13
Documents
11
Period of Report
2024-01-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K dtil-20240107.htm   iXBRL 8-K 67668
2 EX-99.1 dtil-ex99_1.htm EX-99.1 24406
  Complete submission text file 0000950170-24-003761.txt   229349

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT dtil-20240107.xsd EX-101.SCH 29169
5 EXTRACTED XBRL INSTANCE DOCUMENT dtil-20240107_htm.xml XML 4896
Mailing Address 302 EAST PETTIGREW STREET SUITE A-100 DURHAM NC 27701
Business Address 302 EAST PETTIGREW STREET SUITE A-100 DURHAM NC 27701 919-314-5512
PRECISION BIOSCIENCES INC (Filer) CIK: 0001357874 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38841 | Film No.: 24528038
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)